Top 10 Cancer Breakthroughs Of 2011

First Posted: 01/04/12 04:21 PM ET Updated: 01/04/12 07:35 PM ET

Cancer

There were a number of significant cancer research discoveries in 2011, according to the Canadian Cancer Society, and many of them were made by Canadian researchers.


"2011 has been a very exciting year for cancer research," spokesman Sarah Bouma said in a release announcing the society's top 10 findings on Wednesday. "Society-funded researchers have made tremendous gains, particularly in clinical trials."


The top 10 list:


- A clinical trial involving Aromasin’s (exemestane) ability to prevent breast cancer suggests it cuts the risk in high-risk women by 65 per cent.


- A Toronto-based research team establishes a surveillance protocol for families with Li-Fraumeni syndrome — a disease that significantly increases cancer risk — that increases the survival rate to 100 per cent after detection.


- Researchers identify a human blood stem cell that is capable of regenerating the entire blood system.


- A Canadian clinical trial suggests additional radiation in early-stage breast cancer can improve disease-free survival by 30 per cent and reduce the risk of recurrence.


- Variants in the genetic material of ovarian cancer cells provide insight into how ovarian cancer develops.


- A clinical trial funded by the Canadian Cancer Society finds that men with prostate cancer can take a drug holiday and reduce side effects of therapy.


- A new imaging method, Laser Raman Spectroscopy, combined with existing methods is able to identify pre-cancerous lung nodules with 96 per cent accuracy and 91 per cent specificity, when used with existing methods.


- Researchers develop nanoparticles called porphysomes that may effectively target and destroy tumours by converting light from a laser into energy that kills cancer cells.


- A Health Canada study that found young men in Western Canada are the primary users of smokeless tobacco will help develop a tobacco-control strategy aimed at young people.


- Researchers turn their attention to genes that decrease the risk of lymphoblastic leukemia in children in hopes of developing treatment options.


FOLLOW HUFFPOST CANADA LIVING

There were a number of significant cancer research discoveries in 2011, according to the Canadian Cancer Society, and many of them were made by Canadian researchers. "2011 has...
There were a number of significant cancer research discoveries in 2011, according to the Canadian Cancer Society, and many of them were made by Canadian researchers. "2011 has...
Filed by Christian Cotroneo  | 
 
 
  • Comments
  • 3
  • Pending Comments
  • 0
  • View FAQ
Comments are closed for this entry
View All
Favorites
Recency  | 
Popularity
This user has chosen to opt out of the Badges program
photo
fumes
midnight toker
11:46 PM on 01/04/2012
"Pancreatic adenocarcinomas are among the most malignant forms of cancer and, therefore, it is of especial interest to set new strategies aimed at improving the prognostic of this deadly disease. The present study was undertaken to investigate the action of cannabinoids, a new family of potential antitumoral agents, in pancreatic cancer. We show that cannabinoid receptors are expressed in human pancreatic tumor cell lines and tumor biopsies at much higher levels than in normal pancreatic tissue. Studies conducted with MiaPaCa2 and Panc1 cell lines showed that cannabinoid administration (a) induced apoptosis, (b) increased ceramide levels, and (c) up-regulated mRNA levels of the stress protein p8. Cannabinoids also reduced the growth of tumor cells in two animal models of pancreatic cancer. In addition, cannabinoid treatment inhibited the spreading of pancreatic tumor cells. Moreover, cannabinoid administration selectively increased apoptosis and TRB3 expression in pancreatic tumor cells but not in normal tissue. In conclusion, results presented here show that cannabinoids lead to apoptosis of pancreatic tumor cells via a CB2 receptor and de novo synthesized ceramide-dependent up-regulation of p8 and the endoplasmic reticulum stress–related genes ATF-4 and TRB3. These findings may contribute to set the basis for a new therapeutic approach for the treatment of pancreatic cancer." (Cancer Res 2006; 66(13): 6748-55)
http://cancerres.aacrjournals.org/content/66/13/6748.abstract
This comment has been removed.
08:25 PM on 01/04/2012
If there is no money in finding cures , will we ever find any more cures for any disease or illness . Seems to me there have been no cures for any major disease or illness for many years . Hopefully I'm only misinformed .